Mycobacteria Tuberculosis | List of Frontiers open access articles

Review

Published on 30 Sep 2024

The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis

in Immunological Basis of Tuberculosis

Igor Kudryavtsev
Anna Starshinova
Artem Rubinstein
Anastasia Kulpina
Hong Ling
Min Zhuang
Dmitry Kudlay

Frontiers in Tuberculosis

doi 10.3389/ftubr.2024.1438406

5,150 views
7 citations

Original Research

Published on 07 Nov 2024

IFNγ-secreting T cells that highly express IL-2 potently inhibit the growth of intracellular M. tuberculosis in macrophages

in Microbial Immunology

Liying Zhu
Bo Wang
Jin Gu
Jiayu Zhou
Yuan Wu
Wei Xu
Min Yang
Xia Cai
Hongbo Shen
Lu Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469118

4,043 views
3 citations

Original Research

Published on 15 Nov 2017

Rv2629 Overexpression Delays Mycobacterium smegmatis and Mycobacteria tuberculosis Entry into Log-Phase and Increases Pathogenicity of Mycobacterium smegmatis in Mice

in Microbial Immunology

Dan Liu
Kewei Hao
Wenjie Wang
Chao Peng
Yue Dai
Ruiliang Jin
Wenxi Xu
Lei He
Hongyan Wang
Honghai Wang

Frontiers in Microbiology

doi 10.3389/fmicb.2017.02231

18,983 views
21 citations

Original Research

Published on 04 Jul 2025

miR-107-enriched exosomes promote ROS/wnt/autophagy, inhibit intracellular mycobacterial growth and attenuate lung infection

in Microbial Immunology

Wei Xu
Yuan Wu
Min Yang
Jiayu Zhou
Liying Zhu
Xiaosai Ma
Chonghai Qiu
Ling Shen
Hongbo Shen
Feifei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1567167

3,609 views
1 citation

Mini Review

Published on 25 May 2023

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

in Microbial Immunology

Hazel Morrison
Susan Jackson
Helen McShane

Frontiers in Immunology

doi 10.3389/fimmu.2023.1211388

5,639 views
12 citations

Original Research

Published on 16 Jun 2022

In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10

in Vaccines and Molecular Therapeutics

Qing Zhang
Xiong Lu
Liang Gao
Siyu Tao
Yinghua Ge
Daocheng Cui
Renying Zhu
Wenshu Lu
Jian Wang
Shisong Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2022.872676

4,703 views
6 citations

Review

Published on 16 Oct 2018

Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine

in Microbial Immunology

Chloé Albert-Vega
Dina M. Tawfik
Sophie Trouillet-Assant
Laurence Vachot
François Mallet
Julien Textoris

Frontiers in Immunology

doi 10.3389/fimmu.2018.02367

49,559 views
89 citations

Original Research

Published on 25 Sep 2024

Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis

in Adaptive & Innate Immunity in Infection

Peijun Tang
Xinghua Shen
Jianling Gao
Jianping Zhang
Yanjun Feng
Ji Zhang
Ziyi Huang
Xuefeng Wang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2024.1437207

2,979 views
3 citations

Articles

The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis

IFNγ-secreting T cells that highly express IL-2 potently inhibit the growth of intracellular M. tuberculosis in macrophages

Rv2629 Overexpression Delays Mycobacterium smegmatis and Mycobacteria tuberculosis Entry into Log-Phase and Increases Pathogenicity of Mycobacterium smegmatis in Mice

miR-107-enriched exosomes promote ROS/wnt/autophagy, inhibit intracellular mycobacterial growth and attenuate lung infection

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges

In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10

Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine

Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis